Blog > Tag: Alzheimers
Cognition Therapeutics Receives $75.8M Landmark Grant for Alzheimer’s Clinical Trial
We’re thrilled to announce that Golden Seeds company Cognition Therapeutics recently received a $75.8 million grant to fund a Phase ...
How did she do it? A Q&A with Susan Catalano, chief science officer and founder of Cognition Therapeutics
Golden Seeds is focused on investing in the vibrant opportunities of women-led companies. As such, we work with many talented, ...